U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06891040) titled 'Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis' on March 18.
Brief Summary: A multicenter, randomized, double-blind, vehicle controlled phase II clinical study
Study Start Date: March 31
Study Type: INTERVENTIONAL
Condition:
Atopic Dermatitis
Intervention:
DRUG: VC005 Placebo group
VC005 Placebo group with Local topical application
DRUG: VC005 groups
VC005 group with Local topical application
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Jiangsu vcare pharmaceutical technology co., LTD
Published by HT Digital Content Services with permissi...